Common cancer genetic analysis methods and application study based on TCGA database
Received date: 2018-11-20
Revised date: 2019-01-27
Online published: 2019-02-22
Supported by
Supported by the National Science and Technology Major Projects of New Drugs(2018ZX09301053-001);Supported by the National Science and Technology Major Projects of New Drugs(2018ZX09301039-002);Supported by the National Science and Technology Major Projects of New Drugs(2018ZX09201001-004-001);the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
The development of second-generation sequencing (NGS) technology is providing numerous data which shifts the focus of cancer research from the sequencing of multi-species to the analysis and comparison of select data via high-throughput sequencing. The NGS also facilitates the diversity of available genetic data analysis methods, the constant optimization and innovation of analytical approaches for high-throughput genomics as well as the rapid development of genetic data mining and analysis models. The Cancer Genome Atlas (TCGA) database is a direct result of this work. The TCGA database provides a comprehensive record of genetic data collected from a tumor patient’s sample, including its DNA sequence, transcriptional information, epigenetic modification and related. This review elaborates the latest progress in both the mining algorithm and analysis methods for tumor genomics. Specially, we introduce and review the TCGA database and data analysis approaches while demonstrating its applicability using representative cases. This review may shed light on new tumor-related targets discovery for researchers by means of bid data.
Key words: gene data analysis; TCGA database; cancer
Xin Li,Mengwei Li,Yinan Zhang,Hanmei Xu . Common cancer genetic analysis methods and application study based on TCGA database[J]. Hereditas(Beijing), 2019 , 41(3) : 234 -242 . DOI: 10.16288/j.yczz.18-279
| [1] | George B, Seals S, Aban I . Survival analysis and regression models. J Nucl Cardiol, 2014,21:686-694. | |||
| [2] | Rasmussen L, Pratt N, Hansen MR, Hallas J, Pottegard A . Using the "proportion of patients covered" and the Kaplan- Meier survival analysis to describe treatment persistence. Pharmacoepidemiol Drug Saf, 2018,27:867-871. | |||
| [3] | Hsu CH, Yu M . Cox regression analysis with missing covariates via nonparametric multiple imputation. Stat Methods Med Res, 2018,962280218772592. | |||
| [4] | Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W , Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res, 2015,43:e47. | |||
| [5] | Heyer LJ, Kruglyak S, Yooseph S . Exploring expression data: identification and analysis of coexpressed genes. Genome Res, 1999,9:1106-1115. | |||
| [6] | Bunger R, Mallet RT . Metabolomics and receiver operating characteristic analysis: a promising approach for sepsis diagnosis. Crit Care Med, 2016,44:1784-1785. | |||
| [7] | Grau J, Grosse I, Keilwagen J . PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R. Bioinformatics, 2015,31:2595-2597. | |||
| [8] | Cichonska A, Rousu J, Marttinen P, Kangas AJ, Soininen P, Lehtimaki T, Raitakari OT, Jarvelin MR, Salomaa V, Ala-Korpela M, Ripatti S , Pirinen M. metaCCA: summary statistics-based multivariate meta-analysis of genome-wide association studies using canonical correlation analysis. Bioinformatics, 2016,32:1981-1989. | |||
| [9] | Dimou NL, Tsirigos KD, Elofsson A, Bagos PG . GWAR: robust analysis and meta-analysis of genome-wide association studies. Bioinformatics, 2017,33:1521-1527. | |||
| [10] | Chin L, Andersen JN, Futreal PA . Cancer genomics: from discovery science to personalized medicine. Nature Medicine, 2011,17:297-303. | |||
| [11] | Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn), 2015,19:A68-77. | |||
| [12] | Hanahan D, Weinberg RA . The hallmarks of cancer. Cell, 2000,100:57-70. | |||
| [13] | Sirintrapun SJ, Zehir A, Syed A, Gao J, Schultz N, Cheng DT . Translational bioinformatics and clinical research (biomedical) informatics. Clin Lab Med, 2016,36:153-181. | |||
| [14] | Li QK, Pavlovich CP, Zhang H, Kinsinger CR, Chan DW . Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): a critical step towards the personalized care of renal cancers. Semin Cancer Biol, 2018, DOI: 10.1016/j.semcancer.2018.06.004. | |||
| [15] | Smith CC, Beckermann KE ,Bortone DS, de Cubas AA, Bixby LM, L
/
|